Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 322 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

NCT01946477

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Local Institution - 126 Tucson, Arizona, United States
  • Local Institution - 137 Greenbrae, California, United States
  • Local Institution - 109 Los Angeles, California, United States
  • Local Institution - 104 Pleasant Hill, California, United States
View all 49 locations
View Trial Details
Completed

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

NCT02332850

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

NCT01702831

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada
  • Vancouver General Hospital, Centennial Pavilion, 6th Floor Vancouver, British Columbia, Canada
  • Saint John Regional Hospital, 5DN Research Department, 400 University Ave Saint John, New Brunswick, Canada
  • Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada
View Trial Details
Completed

A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

NCT03652064

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Innovative Clinical Research Inc Cerritos, California, United States
  • Baptist MD Anderson Jacksonville, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States
  • Norton Healthcare Louisville, Kentucky, United States
View all 114 locations
View Trial Details
Completed

A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

NCT03106324

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Innsbruck University Hospital Innsbruck, Austria
  • LKH Hochsteiermark Leoben, Austria
  • University hospital St. Pölten Pölten, Austria
  • CHU Saint-Pierre Brussels, Belgium
View all 125 locations
View Trial Details

Related conditions